Skip to content

Author

Yifan Yu

We have 2 of 9 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Membrane bionic supramolecular nanomaterials for co-delivered of ribociclib and PEG10 siRNA for targeted therapy in breast cancer.

This platform exhibits anti-primary tumor and anti-metastatic efficacy and effectively overcomes anoikis resistance in breast cancer, which correlated with the suppression of the MEK/ERK and STAT3 signaling pathways, offering a promising combination strategy for advanced breast cancer immunotherapy and targeted treatme...

Yifan Yu, Li-Dan Liu, Ying Cai et al. · 2 citations
Open access Jul 2026

Functional CRISPR screens reveal TPL1 lncRNA as a regulator of triple-negative breast cancer hallmarks.

TPL1 is identified as a functionally relevant lncRNA associated with TNBC growth, invasion, and molecular regulatory programs and provides a framework for further mechanistic and translational investigation.

R. Elango, S. Ramnarayanan, Radhakrishnan Vishnubalaji et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.